Navigation Links
Smith & Nephew Endoscopy's BIORAPTOR(TM) 2.3 PK Suture Anchor Provides Secure Repair for Shoulder, Hip Instability

Specially designed delivery system ensures proper placement and anchor


ANDOVER, Mass., March 5 /PRNewswire-FirstCall/ -- Smith & Nephew's (NYSE: SNN; LSE: SN) Endoscopy Division today announced the launch of the BIORAPTOR 2.3 PK Suture Anchor for repair of instability in the hip or shoulder joint. The device is featured at Smith & Nephew Endoscopy's booth at the American Academy of Orthopedic Surgery 75th annual meeting in San Francisco, Calif.

Joint instability results when trauma or overuse causes the labrum, or fibrous cartilage lip that runs along the rim of the socket in the shoulder or hip, to stretch or tear. In the shoulder, labral damage often leads to dislocation or subluxation (partial dislocation), which can be painful and limit range of motion. In the hip, it can trigger a clicking or snapping sensation painful enough to be disabling. In both joints, the misalignment that results from labral tears can lead to osteoarthritis.

Smith & Nephew's BIORAPTOR 2.3 PK anchor is designed to be implanted in the dense bone along the rim of the joint socket. Its small size and design provide strong fixation and allow a surgeon to use more than one to establish multiple attachment points, creating a uniform bumper and stabilizing the joint.

The BIORAPTOR 2.3 PK anchor comes with a delivery system that enables surgeons to place it through a portal, or percutaneously (through the skin).

"The new BIORAPTOR system allows me to precisely place the anchors exactly where I want them to be," said Mr. Damian Griffin, a hip specialist and Professor of Trauma and Orthopaedic Surgery at the University of Warwick in the UK. "Working through the portal, it can be difficult to place the anchor properly. With the ability to use a percutaneous approach, I can hit the rim at the precise angle I want."

Dr. Gary M. Gartsman, a shoulder specialist at Texas Orthopedic Hospital in Houston, said the BIORAPTOR 2.3 PK anchor is the "perfect size for capsular stabilization. It holds well, and I am able to insert it at the oblique angle that is often necessary in Bankart repairs."

The BIORAPTOR 2.3 PK Suture Anchor is the second in Smith & Nephew Endoscopy's family of BIORAPTOR suture anchors. The BIORAPTOR 2.9 Suture Anchor, released in 2004, was designed for use in the shoulder, and later adapted for the hip, one of the most challenging joints to access and repair.

"The numbers of surgeons performing hip and shoulder instability repair arthroscopically is climbing, thanks to the development of tools and techniques such as the BIORAPTOR 2.3 Anchor that make these procedures less traumatic to the patient, and less labor-intensive for the practitioner," said Joe Darling, General Manager and Senior VP of Smith & Nephew Endoscopy's Arthroscopic Repair business unit.

(TM)Trademark of Smith & Nephew. Certain Marks Reg. U.S. Pat. & T.M. Off.

About Us

Smith & Nephew is a global medical technology business, specialising in Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2007 were nearly $3.4 billion.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. In particular, statements regarding planned growth in our business and in our operating margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward- looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.

All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Contact: Joe Metzger, Vice President, Corporate Communications

Smith & Nephew Endoscopy

(978) 749-1330

SOURCE Smith & Nephew Endoscopy
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer
2. GlaxoSmithKline Responds to JAMA Articles
3. The Will and Jada Smith Family Foundation and Maybelline Join Forces With the Lupus Foundation of America for a Star-studded Gala to Raise Awareness for Lupus
4. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against LCA-Vision Inc.
5. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
6. TIGroup Names Dennis M. Smith as Chief Financial Officer
7. The American Liver Foundation Appoints Rick Smith, a Twenty-Year Veteran of The MS Society, as Chief Executive Officer
8. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
9. Smith & Nephew Endoscopys KINSA(R) RC Suture Anchor Designed for Secure Repair of Rotator Cuff Injuries
10. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
11. Smithfield(R) LEAN GENERATION(R) Announces DELI FOR THE CURE(TM)
Post Your Comments:
(Date:6/27/2016)... Aliso Viejo, California (PRWEB) , ... June 27, 2016 , ... ... that are fully customizable inside of Final Cut Pro X," said Christina Austin - ... with another unique style. Final Cut Pro X users can now reveal ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016  In a startling report released today, National ... by lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... of how states are tackling the worst drug crisis in recorded ... – Kentucky , New Mexico ... . Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... Sandra ... ... Astellas is a pharmaceutical company ...
Breaking Medicine Technology: